Intractable ascites without mechanical vascular obstruction after orthotopic liver transplantation: Etiology and clinical outcome of sinusoidal obstruction syndrome

Clinical Transplantation

Volumn 24, Issue 1, 2010, Pages 139-148

  Kitajima, Kumiko ^a   Vaillant, Jean Christophe ^a   Charlotte, Frédéric ^b   Eyraud, Daniel ^b   Hannoun, Laurent ^a  

^a Liver Transplantation Unit   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Glutathione depletion; Intractable ascites; Liver transplantation; Sinusoidal obstruction syndrome; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; ASCITES; CADAVER DONOR; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; DRUG DOSE INCREASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LIVER BIOPSY; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; LYMPHOCYTIC INFILTRATION; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETRANSPLANTATION; SURGICAL DRAINAGE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

AGED; ASCITES; FEMALE; GRAFT REJECTION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; TREATMENT OUTCOME;

EID: 74949128255     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00971.x     Document Type: Article

References (45)

1. Hubscher SG. Histological findings in liver allograft rejection - new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 1991, 18:377.
2. Dousset B, Hubscher SG, Padbury RT. Acute liver allograft rejection - is treatment always necessary. Transplantation 1993, 55:529.
3. Hubscher SG. Diagnosis and grading of liver allograft rejection: a European perspective. Transplant Proc 1996, 28:504.
4. Navasa M, Feu F, Garcia-Pagan JC. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993, 17:355.
5. Ng SS, Yu SC, Lee JF, Lai PB, Lau WY. Hepatic venous outflow obstruction after piggyback liver transplantation by an unusual mechanism: report of a case. World J Gastroenterol 2006, 12:5416.
6. Perkins J. Hepatic venous outflow obstruction after piggyback orthotopic liver transplantation. Liver Transpl 2006, 12:159.
7. Inomata Y, Tanaka K, Egawa H. Application of a tissue expander for stabilizing graft position in living-related liver transplantation. Clin Transplant 1997, 11:56.
8. Zaiko AB, Claus D, Clapuvt P. Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty. Radiology 1989, 170:763.
9. Jelliffe DB, Bras G, Stuart KL. Veno-occlusive disease of the liver. Pediatrics 1954, 14:334.
10. Weitz H, Gokel JM, Loeschke K, Possinger K, Eder M. Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch A Pathol Anat Histol 1982, 395:245.
11. Sterneck M, Wiesner R, Ascher N. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991, 14:806.
12. Sebagh M, Debette M, Samuel D. 'Silent' presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial prediction. Hepatology 1999, 30:1144.
13. Blostein MD, Paltiel OB, Thibault A, Rybka WB. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992, 10:439.
14. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002, 22:623.
15. DeLeve LD, McCuskey RS, Wang X. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999, 29:1779.
16. Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructual observations. Am J Gastroenterol 1988, 83:256.
17. Barbatis C, Woods J, Morton JA, Fleming KA, McMichel A, McGee JOthomampersand. Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. Gut 1981, 22:985.
18. Steinhoff G, Wonigeit K, Pichlmayr R. Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 1988, 45:394.
19. Nagura H, Koshikawa T, Fukuda Y, Asai J. Hepatic vascular endothelial cells heterogeneously express surface antigens associated with monocytes, macrophages and T lymphocytes. Virchows Arch A Pathol Anat Histopathol 1986, 409:407.
20. Gane EJ, Portmann BC, Naoumov NV. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996, 334:815.
21. Sanchez-Fueyo A, Restrepo JC, Quinto L. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 2002, 73:56.
22. Mukherjee S. Fatal liver disease despite sustained eradication of recurrent hepatitis C virus requiring liver retransplantation. Transplantation 2006, 82:286.
23. Madalosso C, de Souza NF, Ilstrup DM, Wiesner RH, Krom RAF. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 1998, 66:294.
24. DeLeve LD. Glutathione defense in non-parenchymal cells. Semin Liver Dis 1998, 18:403.
25. Clavien PA. Sinusoidal endothelial cell injury during hepatic preservation and reperfusion. Hepatology 1998, 28:281.
26. Mckeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1998, 46:178.
27. Fisher A, Mor E, Hytiroglou P. FK506 hepatotoxicity in liver allograft recipients. Transplantation 1995, 59:1631.
28. Shsh S, Budev M, Blazey H, Fairbanks K, Mehta A. Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient. Eur Respir J 2006, 27:1066.
29. Vallet-Pichard A, Rerolle JP, Fontaine H. Veno-occlusive disease of the liver in renal transplant patients. Nephrol Dial Transplant 2003, 18:1663.
30. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996, 23:589.
31. Nurnberger W, Michelmann I, Burdach S, Gobel U. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol 1998, 76:61.
32. Salat C, Holler E, Reinhardt B. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant 1994, 14:747.
33. Bearman SI, Lee JL, Baron AE, McDonald GB. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 1997, 89:1501.
34. Kulkami S, Rodriguez M, Lafuente A. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD). Bone Marrow Transplant 1999, 23:803.
35. Mor E, Pappo O, Bar-Nathan N. Defibrotide for the treatment of veno-occlusive disease after liver transplantation. Transplantation 2001, 72:1237.
36. Senzolo M, Patch D, Cholongitas E. Severe venoocclusive disease after liver transplantation treated with transjuglar intrahepatic portosystemic shunt. Transplantation 2006, 82:132.
37. Levy V, Azoulay D, Rio B. Successful treatment of severe hepatic veno-occlusive disease after allogenic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS). Bone Marrow Transplant 1996, 18:443.
38. Nolte W, Canelo R, Figulla HR. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin. Z Gastroenterol 1998, 36:159.
39. Thuluvath PJ, Bal JS, Mitchell S, Lund G, Venbrux A. TIPS for management of refractory ascites. Dig Dis Sci 2003, 48:542.
40. Rosado B, Kamath PS. Transjuglar intrahepatic portosystemic shunts: an update. Liver Transpl 2003, 9:207.
41. Rössel M, Ochs A, Gülberg V. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000, 342:1701.
42. Senzolo M, Cholongitas E, Patch D, Burroughs AK. TIPS for veno-occlusive disease: is the contraindication real? Hepatology 2005, 42:240.
43. Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002, 37:960.
44. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004, 39:280.
45. Fried MW, Connaghan DG, Sharma S. Transjuglar intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996, 24:588.